Showing results (291-300 of 491) with videos related to
Sort By:
Pageof 50
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 29, 2021
Bacterial and fungal bloodstream infections in solid organ transplant recipients: results from a Danish cohort with nationwide follow-upDina Leth Møller, Søren Schwartz Sørensen, Michael Perch, et al.Cardiovascular Diabetology|February 27, 2022
The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker)Massar Omar, Jesper Jensen, Caroline Kistorp, et al.Open Forum Infectious Diseases|October 18, 2021
Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next-Generation SequencingIsabelle P Lodding, Mette Jørgensen, Marc Bennedbæk, et al.ESC Heart Failure|February 15, 2020
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipientsNiklas Bergh, Einar Gude, Sven-Erik Bartfay, et al.European Heart Journal|November 30, 2023
Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registryJan D Schmitto, Steven Shaw, Jens Garbade, et al.Pharmacoepidemiology and Drug Safety|February 7, 2015
Use of quinine and mortality-risk in patients with heart failure--a Danish nationwide observational studyAnne Gjesing, Gunnar H Gislason, Stefan B Christensen, et al.International Journal of Cardiology. Heart & Vasculature|March 18, 2021
The association of prior carpal tunnel syndrome surgery with adverse cardiovascular outcomes and long-term mortality after aortic valve replacementOscar Westin, Marie D Lauridsen, Søren Lund Kristensen, et al.Circulation. Heart Failure|November 8, 2021
Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical TrialMassar Omar, Jesper Jensen, Daniel Burkhoff, et al.Clinical Transplantation|May 24, 2020
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trialKaspar Broch, Einar Gude, Kristjan Karason, et al.Journal of Internal Medicine|May 26, 2026
Amiodarone-related thyroid dysfunction and associated outcomes in patients with heart failure-A nationwide cohort studySøren Lund Kristensen, Sam Aiyad Ali, Mads Ersbøll, et al.Pageof 50